IP Library › Granted Patent US 10,632,130
Granted Patent B2
US 10,632,130 · App. 15/706,341 · Granted Apr 28, 2020

Dehydroandrosterol and methods of using the same

Inventors: John Dunlop (San Antonio, TX); Dongdong Chen (Shanghai, CN)
A61K31/5685A61K9/0053A61K9/141A61K31/568A61K45/06A61P5/00A61P5/26A61P15/00A61P21/06A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,632,130
App. No.
15/706,341
Granted
Apr 28, 2020
Kind
B2
Abstract

A method of promoting muscle growth consisting of providing a dietary supplement containing an effective amount of dehydroandrosterol to a user. A composition for promoting muscle growth containing an effective amount of dehydroandrosterol.

Claims (15)

1. A method of effecting muscle growth in a user in need of said muscle growth, said method comprising:

providing to the user a composition comprising an effective amount of dehydroandrosterol and androsterone; and

inducing physical stress in the user by performing physical exercise.

2. The method of claim 1 , wherein the composition further comprises at least one ester, ether, or salt of dehydroandrosterol, or a combination thereof.

3. The method of claim 1 , wherein the composition further comprises at least one isomer, stereoisomer, or isostere of dehydroandrosterol, or a combination thereof.

4. The method of claim 1 , wherein the composition further comprises a carrier which carries the dehydroandrosterol and androsterone.

5. The method of claim 4 , wherein the carrier is selected from the group consisting of a solid, a liquid, and combinations thereof.

6. The method of claim 4 , wherein the carrier is shaped and dimensioned to facilitate its oral ingestion.

7. The method of claim 1 , wherein the composition is provided to the user at least once every other day.

8. The method of claim 7 , wherein the composition is provided to the user daily.

9. The method of claim 8 , wherein the composition is provided to the user such that the user is provided between approximately 10 mg and approximately 400 mg daily of dehydroandrosterol.

10. The method of claim 1 , wherein the composition further comprises an absorption enhancing agent.

11. The method of claim 10 , wherein the absorption enhancing agent is a half-life enhancing agent.

12. The method of claim 1 , wherein the relative amount of dehydroandrosterol and androsterone in the composition is between approximately 1:4 and approximately 1:100.

13. The method of claim 1 , wherein the composition comprises more than one form of dehydroandrosterol.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2025
From: GENERIC PHARMA LLC
To: 3AD LLC
Reel/Frame 071777/0858 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2021
From: ADVANCED GENETIX
To: GENERIC PHARMA LLC
Reel/Frame 057411/0404 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2020
From: ACCELERATED GENETIX, LLC
To: ADVANCED GENETIX
Reel/Frame 053113/0326 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2017
From: DUNLOP, JOHN; CHEN, DONGDONG
To: ACCELERATED GENETIX, LLC
Reel/Frame 044218/0822 →
Continuity (2)
Provisional Application 62395124 · Sep 15, 2016
Related Publication 20180071314A1 · Mar 15, 2018